The Role of Serology Testing in the Context of Immunization Policies for COVID-19 in Latin American Countries
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Serology Testing in the Context of Immunization Policies for COVID-19 in Latin American Countries
Authors
Keywords
-
Journal
Viruses-Basel
Volume 13, Issue 12, Pages 2391
Publisher
MDPI AG
Online
2021-12-01
DOI
10.3390/v13122391
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling
- (2021) Carleen Klumpp-Thomas et al. Nature Communications
- Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques
- (2021) Rong Li et al. Cellular & Molecular Immunology
- SARS‐CoV‐2 re‐infection risk in Austria
- (2021) Stefan Pilz et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020
- (2021) Anna Jeffery-Smith et al. Eurosurveillance
- COVID-19 antibody seroprevalence in Santa Clara County, California
- (2021) Eran Bendavid et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
- (2021) Merryn Voysey et al. LANCET
- Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
- (2021) Ester C Sabino et al. LANCET
- Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein
- (2021) Houriiyah Tegally et al. NATURE
- SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
- (2021) Constantinos Kurt Wibmer et al. NATURE MEDICINE
- Performance of SARS-CoV-2 serology tests: Are they good enough?
- (2021) Isabelle Piec et al. PLoS One
- Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
- (2021) Nicholas G. Davies et al. SCIENCE
- Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera
- (2021) Alexander Muik et al. SCIENCE
- Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
- (2021) Tjede Funk et al. Eurosurveillance
- Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses
- (2021) Jennifer Hicks et al. JOURNAL OF CLINICAL IMMUNOLOGY
- WHO International Standard for anti-SARS-CoV-2 immunoglobulin
- (2021) Paul A Kristiansen et al. LANCET
- Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study
- (2021) Christian Holm Hansen et al. LANCET
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
- (2021) Eric J Haas et al. LANCET
- SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
- (2021) Victoria Jane Hall et al. LANCET
- Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
- (2021) Katherine R W Emary et al. LANCET
- Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
- (2021) Sandile Cele et al. NATURE
- Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7
- (2021) Nicholas G. Davies et al. NATURE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Vivek Shinde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
- (2021) Nuno R. Faria et al. SCIENCE
- Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
- (2021) Jamie Lopez Bernal et al. BMJ-British Medical Journal
- SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study
- (2021) Andrew G Letizia et al. Lancet Respiratory Medicine
- Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021
- (2021) Mark W. Tenforde et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study
- (2021) Mark S Graham et al. Lancet Public Health
- A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay
- (2021) Gaetano Donofrio et al. Vaccines
- Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
- (2021) Maria Prendecki et al. ANNALS OF THE RHEUMATIC DISEASES
- Increased Household Secondary Attacks Rates With Variant of Concern Severe Acute Respiratory Syndrome Coronavirus 2 Index Cases
- (2021) Sarah A Buchan et al. CLINICAL INFECTIOUS DISEASES
- Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021
- (2021) Finlay Campbell et al. Eurosurveillance
- Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study
- (2021) Kate Causey et al. LANCET
- SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness
- (2021) Aziz Sheikh et al. LANCET
- Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study
- (2021) Peter Bager et al. LANCET INFECTIOUS DISEASES
- Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
- (2021) Katherine A Twohig et al. LANCET INFECTIOUS DISEASES
- Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study
- (2021) Denis Sauré et al. LANCET INFECTIOUS DISEASES
- Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom
- (2021) Emma Pritchard et al. NATURE MEDICINE
- Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States
- (2021) Heather Kalish et al. Science Translational Medicine
- Evidence for antibody as a protective correlate for COVID-19 vaccines
- (2021) Kristen A. Earle et al. VACCINE
- Outbreak of SARS-CoV-2 B.1.617.2 (Delta) Variant Infections Among Incarcerated Persons in a Federal Prison — Texas, July–August 2021
- (2021) Liesl M. Hagan et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination
- (2021) Tom G. Caniels et al. Science Advances
- SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India
- (2021) Sarah Cherian et al. Microorganisms
- The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
- (2021) Elisa Teyssou et al. JOURNAL OF INFECTION
- Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
- (2021) Shuo Feng et al. NATURE MEDICINE
- The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data
- (2021) Aharona Glatman-Freedman et al. EBioMedicine
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
- (2020) Wanbo Tai et al. Cellular & Molecular Immunology
- Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- (2020) Jiuxin Qu et al. CLINICAL INFECTIOUS DISEASES
- Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients
- (2020) Hai-qiong Yu et al. EUROPEAN RESPIRATORY JOURNAL
- Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020
- (2020) Neeraj Sood et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Interpreting Diagnostic Tests for SARS-CoV-2
- (2020) Nandini Sethuraman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The important role of serology for COVID-19 control
- (2020) Amy K Winter et al. LANCET INFECTIOUS DISEASES
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
- (2020) Kelvin Kai-Wang To et al. LANCET INFECTIOUS DISEASES
- Virological assessment of hospitalized patients with COVID-2019
- (2020) Roman Wölfel et al. NATURE
- A serological assay to detect SARS-CoV-2 seroconversion in humans
- (2020) Fatima Amanat et al. NATURE MEDICINE
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village
- (2020) Michael Day BMJ-British Medical Journal
- Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-Analysis
- (2020) Panagiota I. Kontou et al. Diagnostics
- Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections
- (2020) Ger Rijkers et al. JOURNAL OF INFECTIOUS DISEASES
- Convergent antibody responses to SARS-CoV-2 in convalescent individuals
- (2020) Davide F. Robbiani et al. NATURE
- The challenges of modeling and forecasting the spread of COVID-19
- (2020) Andrea L. Bertozzi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation
- (2020) Antonio E. Muruato et al. Nature Communications
- The socio-economic implications of the coronavirus pandemic (COVID-19): A review
- (2020) Maria Nicola et al. International Journal of Surgery
- Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis
- (2020) Mayara Lisboa Bastos et al. BMJ-British Medical Journal
- Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection
- (2020) Jinkai Wan et al. Cell Reports
- COVID-19 Serological Tests: How Well Do They Actually Perform?
- (2020) Abdi Ghaffari et al. Diagnostics
- Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate
- (2020) Amin Addetia et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Are we underestimating seroprevalence of SARS-CoV-2?
- (2020) Stephen Burgess et al. BMJ-British Medical Journal
- Responses to COVID-19 in five Latin American countries
- (2020) María Alejandra Benítez et al. Health Policy and Technology
- Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients
- (2020) Anita S. Iyer et al. Science Immunology
- Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity
- (2020) Kathleen M. McAndrews et al. JCI Insight
- Symptomatic SARS-CoV-2 reinfection of a health care worker in a Belgian nosocomial outbreak despite primary neutralizing antibody response
- (2020) Philippe Selhorst et al. CLINICAL INFECTIOUS DISEASES
- Effect of D614G Spike Variant on Immunoglobulin G, M, or A Spike Seroassay Performance
- (2020) Carleen Klumpp-Thomas et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
- (2020) Sheila F. Lumley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insights from Patterns of SARS-CoV-2 Immunoglobulin G Serology Test Results from a National Clinical Laboratory, United States, March–July 2020
- (2020) Harvey W. Kaufman et al. Population Health Management
- Serological follow-up of SARS-CoV-2 asymptomatic subjects
- (2020) Gregorio Paolo Milani et al. Scientific Reports
- Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples
- (2020) Livia Mazzini et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development
- (2018) Ligia A. Pinto et al. VACCINE
- Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countries
- (2016) Felicity T. Cutts et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Nomenclature for Immune Correlates of Protection After Vaccination
- (2012) S. A. Plotkin et al. CLINICAL INFECTIOUS DISEASES
- An Automated HIV-1 Env-Pseudotyped Virus Production for Global HIV Vaccine Trials
- (2012) Anke Schultz et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More